Sign in to view content

The Functional Burden of Diabetic Retinopathy in the United States – How Ranibizumab May Shift Treatment Paradigms

Jeffrey R Willis, MD/PhD

Video
Published 2017

Related

2-Year Outcomes From Randomized Trials of Anti-VEGF Treatments for Diabetic Retinopathy (DR) and Diabetic Macular Edema (DME)
Geeta A. Lalwani, MD
Annual Meeting Talks
2018
Faricimab Response is Associated With Intraocular Pressure Lowering in Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration
Tamara L Lenis, MD, PhD
Annual Meeting Talks
2024
Impact of Faricimab vs Aflibercept on Epiretinal Membrane Formation Over 2 Years in Eyes With DME in the YOSEMITE/RHINE Phase 3 Trials
Glenn J. Jaffe, MD
Annual Meeting Talks
2023

Category: Diabetic Retinopathy

See more